I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Anesthesiologist Joshua Hackett grew up in Chico, attended Chico State, and now practices in Humboldt County. He has a ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

ITV viewers slammed the show for 'sending a dangerous message' and 'medical misinformation' after a guest, showcased her before and after pictures.

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

Upcoming Investor Conference Skye Bioscience will be a corporate presenter at the 43 rd annual J.P. Morgan Healthcare Conference Thursday, January 16, 2025, at 10:30 AM - 11:10 AM and is available for ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?